NLRC5 and neoplasm: Circulating T cells derived from NLRC5-overexpressing tumor-bearing mice showed a greater ability to be activated, producing higher amounts of IFN-γ and displaying higher expression of T-bet and Eomes transcription factors which are known to cooperate to regulate CD8+ T cell effector function (60).